- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Race Oncology Ltd (RAC)
Race Oncology Ltd stock price live, this page displays ASX RAC stock exchange data. View the RAC premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Race Oncology Ltd real time stock price chart below.
What Is the Race Oncology Ltd Stock Price Today?
The Race Oncology Ltd stock price today is 4.170.
What Is the Stock Symbol for Race Oncology Ltd?
The stock symbol for Race Oncology Ltd is ""RAC.""
What Stock Exchange Does Race Oncology Ltd Trade On?
Race Oncology Ltd is listed and trades on the Sydney stock exchange.
Is Race Oncology Ltd a Good Stock to Buy?
Determining whether Race Oncology Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RAC quote. (ISIN: AU000000RAC3)
What Is the Race Oncology Ltd Stock Price Today?
The Race Oncology Ltd stock price today is 4.170.
What Is the Stock Symbol for Race Oncology Ltd?
The stock symbol for Race Oncology Ltd is ""RAC.""
What Stock Exchange Does Race Oncology Ltd Trade On?
Race Oncology Ltd is listed and trades on the Sydney stock exchange.
Is Race Oncology Ltd a Good Stock to Buy?
Determining whether Race Oncology Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RAC quote. (ISIN: AU000000RAC3)
Sydney
Currency in AUD
4.170
-0.010(-0.24%)
Delayed Data·
Fair Value
An estimate of a Race Oncology's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.090
4.220
52 wk Range
0.920
4.900
RAC is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Race Oncology's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.0904.220
52 wk Range
0.9204.900
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Neutral
RAC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Race Oncology's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
Race Oncology Ltd Company Profile
Race Oncology Limited, a clinical stage biopharmaceutical company, focuses on addressing the unmet needs of cancer patients for damaging treatments in Australia. The company’s lead product is bisantrene, a small molecule chemotherapeutic that has a clinical history with demonstrated therapeutic benefits in adult and paediatric patients. It is advancing reformulated bisantrene (RC220) to address the unmet need of patients across various oncology indications with a clinical focus on anthracycline combination to deliver cardioprotection and enhanced anticancer activity in solid tumors. It also exploring RC220 as a low intensity treatment for acute myeloid leukaemia. In addition, the company investigating the effect of bisantrene on the m6A RNA pathway, following independent research identifying bisantrene as the potent inhibitor of fat mass and obesity-associated protein. It has collaborations with Astex, MD Anderson, Sheba City of Health, University of North Carolina School of Medicine, University of Wollongong, and University of Newcastle. The company was formerly known as Coronado Resources Limited. Race Oncology Limited was incorporated in 2011 and is headquartered in Sydney, Australia.
Compare RAC to Peers and Sector
Metrics to compare | RAC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRACPeersSector | |
|---|---|---|---|---|
P/E Ratio | −152.2x | −4.6x | −0.7x | |
PEG Ratio | −2.27 | −0.04 | 0.00 | |
Price/Book | 45.5x | 4.2x | 2.6x | |
Price / LTM Sales | 120.5x | 10.0x | 3.3x | |
Upside (Analyst Target) | 52.4% | 216.4% | 37.1% | |
Fair Value Upside | Unlock | −4.8% | 4.7% | Unlock |
Earnings
Latest Release
Aug 26, 2025
EPS / Forecast
-0.03 / --
Revenue / Forecast
788.42K / --
People Also Watch
FAQ
What Stock Exchange Does Race Oncology Trade On?
Race Oncology is listed and trades on the Sydney Stock Exchange stock exchange.
What Is the Stock Symbol for Race Oncology?
The stock symbol for Race Oncology is "RAC."
What Is the Race Oncology Market Cap?
As of today, Race Oncology market cap is 714.45M.
What Is Race Oncology's Earnings Per Share (TTM)?
The Race Oncology EPS (TTM) is -0.03.
From a Technical Analysis Perspective, Is RAC a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Race Oncology Stock Split?
Race Oncology has split 0 times.
How Many Employees Does Race Oncology Have?
Race Oncology has 0 employees.
What is the current trading status of Race Oncology (RAC)?
As of 17 Oct 2025, Race Oncology (RAC) is trading at a price of 4.170, with a previous close of 4.18. The stock has fluctuated within a day range of 4.090 to 4.220, while its 52-week range spans from 0.920 to 4.900.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.